Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday

Hookipa Pharma (NASDAQ:HOOK) is expected to issue its quarterly earnings data before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($0.41) per share and revenue of $3.44 million for the quarter.

Hookipa Pharma Stock Performance

HOOK stock opened at $1.23 on Friday. Hookipa Pharma has a 52 week low of $1.11 and a 52 week high of $10.50. The firm’s fifty day moving average is $1.70 and its 200 day moving average is $2.78. The firm has a market cap of $14.83 million, a P/E ratio of -0.33 and a beta of 0.71.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. JMP Securities cut their price target on shares of Hookipa Pharma from $24.00 to $7.00 and set a “market outperform” rating on the stock in a report on Thursday, November 21st. Royal Bank of Canada lowered shares of Hookipa Pharma from an “outperform” rating to a “sector perform” rating and cut their price target for the stock from $48.00 to $2.00 in a report on Friday, December 20th. Finally, HC Wainwright reissued a “neutral” rating on shares of Hookipa Pharma in a report on Friday, January 10th.

About Hookipa Pharma

HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.